A detailed history of Virtu Financial LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Virtu Financial LLC holds 17,917 shares of ROIV stock, worth $205,866. This represents 0.01% of its overall portfolio holdings.

Number of Shares
17,917
Holding current value
$205,866
% of portfolio
0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024

BUY
$10.17 - $12.5 $182,215 - $223,962
17,917 New
17,917 $207,000
Q4 2023

Feb 26, 2024

BUY
$8.38 - $11.58 $101,548 - $140,326
12,118 New
12,118 $136,000
Q1 2022

May 17, 2022

SELL
$4.74 - $9.91 $95,572 - $199,815
-20,163 Closed
0 $0
Q4 2021

Feb 17, 2022

BUY
$5.86 - $13.52 $118,155 - $272,603
20,163 New
20,163 $203,000

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.09B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.